Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

Item
http://www.wikidata.org/entity/Q30364932
Advancements in the development of subunit influenza vaccinesThe avian influenza vaccine Emerflu. Why did it fail?Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.Progress in developing virus-like particle influenza vaccines.Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomesT cells control the generation of nanomolar-affinity anti-glycan antibodiesNext generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles.Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments.Monitoring the Disassembly of Virus-like Particles by 19F-NMR.Vaccine approaches conferring cross-protection against influenza viruses.Escherichia coli-derived virus-like particles in vaccine development.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Disease Vaccine.Novel Platforms for the Development of a Universal Influenza Vaccine.
P2860

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

Item
http://www.wikidata.org/entity/Q30364932
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@ast
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@en
type
label
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@ast
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@en
prefLabel
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@ast
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Safety and immunogenicity of a ...... l in healthy Asian volunteers.
@en
P2093
P304
P31
P356
10.1016/J.VACCINE.2014.07.011
P407
P433
P478
P50
P577
P5875
P698
P921